%PDF-1.4
%
4 0 obj
<2 \(somatostatin receptor subtype 2\)-preferring SSA should be evaluated in more detail.)/Title(Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells)/Trapped/False>>
endobj
5 0 obj
<>stream
Herrera-Martínez A.D.; Feelders R.A.; Van den Dungen R.; Dogan-Oruc F.; van Koetsveld P.M.; Castaño J.P.; de Herder W.W.; Hofland L.J.
Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.<br />
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.<br />
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Serotonin, a biologically active amine, is related to carcinoid syndrome in functioning neuroendocrine tumors (NETs). Telotristat ethyl is a novel inhibitor of the tryptophan hydroxylase (TPH), a key enzyme in the production of serotonin. While its use in patients with carcinoid syndrome and uncontrolled diarrhea under somatostatin analogs (SSAs) has been recently approved, in vitro data evaluating its effectiveness are lacking. For this reason, we aimed to evaluate the effect of telotristat as monotherapy, and in combination with SSAs, on proliferation and secretion in a NET cell line model. The human pancreatic NET cell lines BON-1/QGP-1 were used as 2D and 3D cultured models; somatostatin receptor and TPH mRNA expression, as well as the potential autocrine effect of serotonin on tumor cell proliferation using a 3D culture system were evaluated. Telotristat decreased serotonin production in a dose-dependent manner at a clinically feasible concentration, without affecting cell proliferation. Its combination with pasireotide, but not with octreotide, had an additive inhibitory effect on serotonin secretion. The effect of telotristat was slightly less potent, when BON-1 cells were co-treated with octreotide. Octreotide and pasireotide had no effect on the expression of TPH. Telotristat did not have an effect on mRNA expression of somatostatin receptor subtypes. Finally, we showed that serotonin did not have an autocrine effect on NET cell proliferation on the 3D cell model. These results suggest that telotristat is an effective drug for serotonin inhibition, but the effectiveness of its combination with SST<sub>2</sub> (somatostatin receptor subtype 2)-preferring SSA should be evaluated in more detail.
Telotristat
In vitro effect
Neuroendocrine tumors
Serotonin secretion
Growth
endstream
endobj
6 0 obj
<>stream
x+ |
endstream
endobj
7 0 obj
<>stream
x}
@sκ۪"
ko00۔=@q5Xbkgo2:D]J8),bWeák0¾ʕE$R%"&+. L:BN"EJG[fY>3=;C
endstream
endobj
8 0 obj
<>stream
x+ |
endstream
endobj
9 0 obj
<>stream
x}
@s۪"
ko00۔ Ԟ m,`LDؖƀ&eUiLai/#_E·wyT7~*WK4 _qT
0!
E*Uֻme7 ;G
endstream
endobj
10 0 obj
<>stream
x+ |
endstream
endobj
11 0 obj
<>stream
x}
@sκ۪"
ko00۔(=@q5Xb`!4etD1,EYpSXG%Œ\ۻC<*a}?+I̥KPEMW\*u(E*ݏ̲|:;K
endstream
endobj
12 0 obj
<>stream
x+ |
endstream
endobj
13 0 obj
<>stream
x}
@sκ몷"
ko00Px&(8B*hljc@YlGʪ8eFKJ$w7ηakWK.Aq4)T
0!P
9U&VmeŜ'>;O
endstream
endobj
14 0 obj
<>stream
x+ |
endstream
endobj
15 0 obj
<>stream
x}
@sκ۪"
ko00۔P{&jP\=3|sDؖƀ&eUiLai/Kf/so]o0T,%1z.Aq4 _q`Bԡr)T"w?2)/Bm;S
endstream
endobj
16 0 obj
<>stream
x+ |
endstream
endobj
17 0 obj
<>stream
x}A@+XםuUoE;t5H]+"AfO
O
2aeks }!8RGěR)>YWwTp3XJ8mڇc